Weekly News Round-up – 1/4/21
6 years ago
By Charlotte Di Salvo

In the news this week, GSK agrees to support NOVAVAX vaccine production to meet UK targets. In other news, Amgen Inc. confirms its agreement to acquire Rodeo Therapeutics, and COVID-19 vaccine production is boosted by expansions in production with BioNtech and Pfizer.
GSK SUPPORTS NOVAVAX COVID 19 VACCINE MANUFACTURING – In collaboration with NOVAVAX and the UK’s Vaccines Task Force, GSK has agreed to support the manufacturing of up to 60 million COVID-19 vaccines. The recent partnership could increase production capacity and meet the April 15 deadline to offer a first dose to all over 50’s.
AMGEN TO ACQUIRE RODEO THERAPEUTICS – Under a new agreement, Amgen Inc. will acquire Rodeo Therapeutics Corporation. The strategic move by Amgen seeks to collaborate with Rodeo’s enzyme programme (15-PGDH) to develop ‘first-in-class’ therapeutics alongside Amgen’s inflammation research. Any outstanding shares of Rodeo will be acquired by Amgen in exchange for an upfront payment of $55 million.
2021 VACCINE TARGET BOOSTED BY BIONTECH-PFIZER – With further manufacturing capacity, expansion BioNTech and Pfizer could deliver 2.5 billion COVID-19 doses by 2022. The recent addition of BioNTech’s latest facility in Marburg, Germany, has resulted in expansion of the manufacturing and supply network to accelerate commercial production.
R&D
IBM unveils next steps in AI technology with quantum computer
Clinical
First cell-based gene therapy approved for Adult Multiple Myeloma by FDA
Manufacturing
Human error costs J&J 15 million COVID-19 vaccines
That’s all for now. See you next week!
Charlotte Di Salvo, Junior Medical Writer
Proventa International
Rethinking Clinical Trial Outsourcing: Site Selection, CRO Partnerships & Global Competitiveness
Are traditional clinical trial outsourcing models still fit for purpose, or does the industry need to rethink how sponsors, CROs and investigative sites collaborate? Insights from Proventa International's Clinical Operations & Clinical Trial Supply Chain Strategy Meeting Europe, London |...
1 week agoRethinking Clinical Trial Outsourcing: Site Selection, CRO Partnerships & Global Competitiveness
Are traditional clinical trial outsourcing models still fit for purpose, or does the industry need to rethink how sponsors, CROs and investigative sites collaborate? Insights from Proventa International's Clinical Operations & Clinical Trial Supply Chain Strategy Meeting Europe, London |...
1 week ago
Navigating the Complex World of Global Regulatory Affairs in Oncology
In today's fast-paced global pharmaceutical landscape, the regulatory affairs sector plays a pivotal role in ensuring the safety, efficacy, and market access of oncology drugs. As the demand for innovative cancer therapies continues to grow, understanding the intricacies of global...
3 years agoNavigating the Complex World of Global Regulatory Affairs in Oncology
In today's fast-paced global pharmaceutical landscape, the regulatory affairs sector plays a pivotal role in ensuring the safety, efficacy, and market access of oncology drugs. As the demand for innovative cancer therapies continues to grow, understanding the intricacies of global...
3 years ago
Overcoming the Hurdles: Navigating the Challenges in Oncology Clinical Trials
In the world of medical research, oncology clinical trials are at the forefront of innovation and discovery. These trials play a crucial role in advancing our understanding of cancer and developing more effective treatments. However, the path to successful oncology...
3 years agoOvercoming the Hurdles: Navigating the Challenges in Oncology Clinical Trials
In the world of medical research, oncology clinical trials are at the forefront of innovation and discovery. These trials play a crucial role in advancing our understanding of cancer and developing more effective treatments. However, the path to successful oncology...
3 years ago